Research ID
hum0302-v1Release info
Research title
iPS Cell Advanced Characterization and Development of modified iPS cells
Research overview
- Aims
- To characterize iPS cell lines (healthy-donor iPS cell lines and disease-specific iPS cell lines), differentiation potential analysis (evaluation of differentiation potential into disease-causing cells and involved cells), disease-causing gene analysis, and whole genome analysis were performed.
- Methods
- [JGAS000382] Hepatocytes were induced to differentiate from human iPS cells and collected on day 19. RNA was collected and strand-specific library preparation was performed by a PolyA selection method. The prepared library was sequenced by Novaseq6000. Sequencing was performed in a 2x150 bp PE configuration with a data output of about 6 Gb per sample (equivalent to about 20 million paired reads).
[JGAS000683] Kidney organoids were induced to differentiate from human iPS cells and collected on day 18. RNA was collected and strand-specific library preparation was performed by a PolyA selection method. The prepared library was sequenced by Novaseq6000. Sequencing was performed in a 2x150 bp PE configuration with a data output of about 6 Gb per sample (equivalent to about 20 million paired reads). - Participants/materials
- iPS cells derived from patients with Wilson's disease, juvenile nephron tabes (NPH1) patients and iPS cells derived from healthy donors
Datasets
The list is the one this version published; each dataset's content is shown as it is now.
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000497 | NGS (RNA-seq) |
| Controlled-access (Type I) | 2021-11-10 |
Data provider
- Principal investigator
- Yohei Hayashi
- Affiliation
- RIKEN BioResource Research Center
Research projects
| Name | URL |
|---|---|
iPS Cell Advanced Characterization and Development Team |
Grants
No grants.
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes. |
Controlled access users
No use of the controlled access data has been recorded.